Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Back

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 24, 2018
FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes - A pilot studyDavid L Chan, Edward Hsiao, Geoff Schembri, et al.
Cold Spring Harbor Molecular Case Studies|January 4, 2020
Molecular and clonal evolution in recurrent metastatic gliosarcomaKevin J Anderson, Aaron C Tan, Jonathon Parkinson, et al.
Cancers|October 13, 2021
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Frontiers in Oncology|October 4, 2021
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical ReviewByeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine CareThilo Schuler, Stephanie Roderick, Shelley Wong, et al.
Neuro-Oncology|May 13, 2021
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU studyHao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, et al.
Medicines (Basel, Switzerland)|June 13, 2018
Accreditation Standard Guideline Initiative for Tai Chi and Qigong Instructors and Training InstitutionsByeongsang Oh, Albert Yeung, Penelope Klein, et al.
The Lancet. Oncology|October 1, 2016
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyJaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, et al.
The New England Journal of Medicine|March 16, 2017
Short-Course Radiation plus Temozolomide in Elderly Patients with GlioblastomaJames R Perry, Normand Laperriere, Christopher J O'Callaghan, et al.
Journal of Neuro-Oncology|October 15, 2025
Vaccine-induced immunity is maintained in glioma patients relative to other solid tumoursAlexander Yuile, Joe Q Wei, Kelly J McKelvey, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 24, 2018
FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes - A pilot studyDavid L Chan, Edward Hsiao, Geoff Schembri, et al.
Cold Spring Harbor Molecular Case Studies|January 4, 2020
Molecular and clonal evolution in recurrent metastatic gliosarcomaKevin J Anderson, Aaron C Tan, Jonathon Parkinson, et al.
Cancers|October 13, 2021
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Frontiers in Oncology|October 4, 2021
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical ReviewByeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine CareThilo Schuler, Stephanie Roderick, Shelley Wong, et al.
Neuro-Oncology|May 13, 2021
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU studyHao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, et al.
Medicines (Basel, Switzerland)|June 13, 2018
Accreditation Standard Guideline Initiative for Tai Chi and Qigong Instructors and Training InstitutionsByeongsang Oh, Albert Yeung, Penelope Klein, et al.
The Lancet. Oncology|October 1, 2016
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyJaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, et al.
The New England Journal of Medicine|March 16, 2017
Short-Course Radiation plus Temozolomide in Elderly Patients with GlioblastomaJames R Perry, Normand Laperriere, Christopher J O'Callaghan, et al.
Journal of Neuro-Oncology|October 15, 2025
Vaccine-induced immunity is maintained in glioma patients relative to other solid tumoursAlexander Yuile, Joe Q Wei, Kelly J McKelvey, et al.
Pageof 9